Management and Advisors

OUR TEAM

Meet the experts behind our company

Meet the folks who make it all happen. We see big potential in every moment, and care deeply about what we do every day. Our leadership team has a remarkable breadth and depth of experience in phenotypic drug research and development against non-alcoholic steatohepatitis.

Jan Lichtenberg, CEO

jan.lichtenberg@syndya-therapeutics.com

Jan has founded several successful companies in the life science and technology space. Based on a decade of experience in phenotypic drug screening, Syndya is his newest venture. He is also CEO of InSphero, which he co-founded in 2009.
Button
Frank Junker, CBO

frank.junker@syndya-therapeutics.com

As a co-founder, Frank brings 20 years of business-development, marketing and strategy experience to Syndya. He is also the Chief Business Officer of InSphero.
Button
Nikolai Naoumov, Advisor

Nikolai is an expert in translational research and drug development for liver diseases. With 12 years experience in leadership roles at Novartis Pharma and former UCL Professor of hepatology he supports Syndya as an advisor to shape our discovery strategy for NASH combinations.
Button
Robert Thong, Advisor

Robert is an experienced strategic advisor and business mentor for life-science companies. The visiting lecturer at Cambridge University supports the executive team of Syndya to create sustainable value in the NASH field.
Button

Contact

Wagistrasse 27a

CH-8952 Schlieren

Switzerland

OUR TEAM

Meet the experts behind our company

Jan Lichtenberg, CEO

Frank Junker, CBO

Nikolai Naoumov, Advisor

Robert Thong, Advisor

Contact